What is China National Medicines Price-to-Operating-Cash-Flow?
As of today (2024-05-11), China National Medicines's share price is ¥36.34.
China National Medicines's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.85. Hence, China National Medicines's Price-to-Operating-Cash-Flow Ratio for today is 12.75.
The historical rank and industry rank for China National Medicines's Price-to-Operating-Cash-Flow or its related term are showing as below:
SHSE:600511'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.88 Med: 20.96 Max: 244.21
Current: 12.69
During the past 13 years, China National Medicines's highest Price-to-Operating-Cash-Flow Ratio was 244.21. The lowest was 6.88. And the median was 20.96.
China National Medicines's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥-2.28.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.85.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of China National Medicines was -16.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 28.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 20.50% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 23.00% per year.
During the past 13 years, China National Medicines's highest 3-Year average Operating Cash Flow per Share Growth Rate was 533.30% per year. The lowest was -16.40% per year. And the median was 28.00% per year.
China National Medicines Price-to-Operating-Cash-Flow Historical Data
The historical data trend for China National Medicines's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China National Medicines Price-to-Operating-Cash-Flow Chart
|
China National Medicines Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
11.71 |
28.59 |
12.15 |
8.79 |
7.92 |
|
China National Medicines Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
10.98 |
13.36 |
9.61 |
7.92 |
11.57 |
Competitive Comparison of China National Medicines's Price-to-Operating-Cash-Flow
For the Medical Distribution subindustry, China National Medicines's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China National Medicines's Price-to-Operating-Cash-Flow Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China National Medicines's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where China National Medicines's Price-to-Operating-Cash-Flow falls into.
China National Medicines Price-to-Operating-Cash-Flow Calculation
China National Medicines's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 36.34 | / | 2.851 |
| = | 12.75 |
China National Medicines's Share Price of today is ¥36.34.
China National Medicines's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.85.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
China National Medicines (SHSE:600511) Business Description
Traded in Other Exchanges
N/A
Address
No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.
China National Medicines (SHSE:600511) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:600511 has been successfully added to your